Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma

被引:0
作者
Aramaki, M [1 ]
Matsumoto, T [1 ]
Shibata, K [1 ]
Himeno, Y [1 ]
Yada, K [1 ]
Hirano, S [1 ]
Sasaki, A [1 ]
Kawano, K [1 ]
Kitano, S [1 ]
机构
[1] Oita Med Univ, Dept Surg 1, Oita, Japan
关键词
gallbladder carcinoma;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The overall outcome of T2 gallbladder carcinoma has not been favorable, although there is a modest hope for long-term survival after radical resection. The aim of this study was to examine factors influencing postoperative disease-free survival of patients with T2 gallbladder carcinoma to clarify optimal treatment. Methodology: Of 53 patients with gallbladder carcinoma who had undergone surgical resection from 1985 to 2000, 22 had T2 carcinoma histologically proved. The significance of variables for disease-free survival was examined retrospectively by the Kaplan-Meier method and the log-rank test. Results: There were 16 patients with stage II (T2N0M0), 6 with stage Ill (T2N1M0) disease. Eleven patients were treated by extended cholecystectomy with resection of the extrahepatic bile duct, 10 patients underwent extended cholecystectomy without resection of the extrahepatic bile duct, and I patient underwent cholecystectomy. All patients under-went lymph node dissection in the hepatoduodenal ligament, below the pancreatic head, and along the common hepatic artery. Lymph node metastasis was present in 6 patients. Lymphatic, venous, and perineural invasions were found in 9, 4, and 4 patients, respectively. The absence of lymphatic invasion was a significant factor related to good postoperative disease-free survival (5-year disease-free survival rate, 88.9% vs. 31.3% in the presence of lymphatic invasion). Lymph node, venous, or perineural invasion, and surgical procedure were not significant factors to good postoperative disease-free survival. Conclusions: For patients with T2 gallbladder carcinoma, the presence of lymphatic invasion is an unfavorable prognostic indicator that calls for additional treatment after radical surgery.
引用
收藏
页码:1609 / 1611
页数:3
相关论文
共 50 条
  • [41] Prognostic factors and long-term results after surgery for gallbladder carcinoma: a retrospective study of 127 patients
    Schauer, RJ
    Meyer, G
    Baretton, G
    Schildberg, FW
    Rau, HG
    LANGENBECKS ARCHIVES OF SURGERY, 2001, 386 (02) : 110 - 117
  • [42] Comparison of the Oncological Outcomes of Open versus Laparoscopic Surgery for T2 Gallbladder Cancer: A Propensity-Score-Matched Analysis
    Cho, Jin-Kyu
    Kim, Jae-Ri
    Jang, Jae-Yool
    Kim, Han-Gil
    Kim, Jae-Myung
    Kwag, Seung-Jin
    Park, Ji-Ho
    Kim, Ju-Yeon
    Ju, Young-Tae
    Jeong, Chi-Young
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [43] Surgical Treatment of pT2 Gallbladder Carcinoma: A Reevaluation of the Therapeutic Effect of Hepatectomy and Extrahepatic Bile Duct Resection Based on the Long-term Outcome
    Hiroshi Yokomizo
    Takaaki Yamane
    Toshihiko Hirata
    Michio Hifumi
    Tetsu Kawaguchi
    Seiji Fukuda
    Annals of Surgical Oncology, 2007, 14 : 1366 - 1373
  • [44] Surgical treatment of pT2 gallbladder carcinoma: A reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome
    Yokomizo, Hiroshi
    Yamane, Takaaki
    Hirata, Toshihiko
    Hifumi, Michio
    Kawaguchi, Tetsu
    Fukuda, Seiji
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) : 1366 - 1373
  • [45] High DBC1 (CCAR2) expression in gallbladder carcinoma is associated with favorable clinicopathological factors
    Won, Kyu Yeoun
    Cho, Hyuck
    Kim, Gou Young
    Lim, Sung-Jig
    Bae, Go Eun
    Lim, Jun Uk
    Sung, Ji-Youn
    Park, Yong-Koo
    Kim, Youn Wha
    Lee, Juhie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 11440 - 11445
  • [46] Recognition of potential therapeutic role of 2-hydroxy-3-methylanthraquinones in the treatment of gallbladder carcinoma: A proteomics analysis
    Jin, Hao
    Cui, Min
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (02) : 350 - 362
  • [47] Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Sakabe, Ryutaro
    Kobayashi, Hironori
    Kondo, Naru
    Nakagawa, Naoya
    Sueda, Taijiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2012, 19 (04) : 306 - 313
  • [48] Simple cholecystectomy is an adequate treatment for grade I T1bN0M0 gallbladder carcinoma: Evidence from 528 patients
    Shao, Jun
    Lu, Hong-Cheng
    Wu, Lin-Quan
    Lei, Jun
    Yuan, Rong-Fa
    Shao, Jiang-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (31) : 4431 - 4441
  • [49] Spontaneous apoptosis in gallbladder carcinoma - Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene
    Sasatomi, E
    Tokunaga, O
    Miyazaki, K
    CANCER, 1996, 78 (10) : 2101 - 2110
  • [50] MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma
    Wang, W.
    Chen, L. -C.
    Qian, J. -Y.
    Zhang, Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 9829 - 9839